moderna’s vaccine against covid19 will vault revenue above 20 billion this year up from less than 1 billion in 2020 the messengerrna technology used by the biotech couldn’t have come of age at a better time investors have rewarded moderna by quadrupling its stock price this year to a high of 444 after the company delivered betterthanexpected earnings that nearly 180 billion market capitalization makes moderna the highestvalued biotech anywhere